Cargando…

1222. Fosfomycin Susceptibility Testing using the new ETEST(®)FO

BACKGROUND: Fosfomycin (FO) is a bactericidal antibiotic with a broad spectrum of activity against a wide range of Gram-positive and Gram-negative bacteria. Oral FO is mainly used in the treatment of urinary tract infections, particularly those caused by E. coli and E. faecalis. In order to determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halimi, Diane, Pompilio, Marion, Fontaine, Sandrine, Martelin, Roland, Franceschi, Christine, Zambardi, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777342/ http://dx.doi.org/10.1093/ofid/ofaa439.1407

Ejemplares similares

656. Sulbactam-Durlobactam MIC Determination: Comparative Evaluation of the New ETEST(®) SUD to the CLSI 2021 Broth Microdilution Method
por: Sauvonnet, Veronique, et al.
Publicado: (2021)

1227. Plazomicin Susceptibility Testing using ETEST(®) MIC for Enterobacterales
por: Ying, Yun, et al.
Publicado: (2020)

644. Comparative Evaluation of ETEST® ERV bioMérieux with the CLSI Broth Microdilution Method for Eravacycline MIC Determination
por: Sauvonnet, Veronique, et al.
Publicado: (2019)

2166. Performance Study on the New ETEST® Piperacillin/Tazobactam (P/T) MIC Strip
por: Martelin, Roland, et al.
Publicado: (2019)

Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales
por: Blanchard, Laurine S., et al.
Publicado: (2022)

Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species
por: Goer, A., et al.
Publicado: (2022)

Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci
por: Blanchard, Laurine S., et al.
Publicado: (2023)

2072. Multicenter Evaluation of the Etest vs. Agar Dilution for Susceptibility Testing of Helicobacter pylori
por: Shakir, Salika M, et al.
Publicado: (2018)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023)

652. Comparison of fosfomycin (FOF) activity and prevalence of subpopulations between Escherichia coli (EC) and Klebsiella pneumoniae (KP) during susceptibility testing
por: Anderson, Jadyn C, et al.
Publicado: (2020)

1690. Oral Fosfomycin for the Treatment of Bacterial Prostatitis
por: Kamath, Meghan, et al.
Publicado: (2020)

2149. Performance of a Gradient Diffusion Method (Etest®) on Mueller–Hinton Agar with Sheep Blood for Aerococcus urinae Antimicrobial Susceptibility Testing
por: Berteau, Tammy, et al.
Publicado: (2019)

1292. Evaluation of Synergy with Piperacillin/Tazobactam plus Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae and Enterobacter cloacae Using ETEST
por: Ashcraft, Deborah S, et al.
Publicado: (2021)

2062. Evaluation of Susceptibility Testing Methods for Fosfomycin Against Enterobacteriaceae and Pseudomonas aeruginosa
por: De La Cadena, Elsa Piedad, et al.
Publicado: (2018)

1222. Ceftolozane-Tazobactam Heteroresistance in Cystic Fibrosis Related Pseudomonas aeruginosa Infections
por: Sanders, James, et al.
Publicado: (2021)

Evaluation of an agar-gradient minimum-inhibitory-concentration method (the Etest) as a rapid and direct measure of antimicrobial susceptibility in Gram-negative bacteraemia
por: Darton, Tom, et al.
Publicado: (2008)

Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis
por: Song, You Bum, et al.
Publicado: (2015)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies
por: Lemes, Raquel M.L., et al.
Publicado: (2010)

Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review
por: Dannaoui, Eric, et al.
Publicado: (2019)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Use of direct Etest in the management of ventilator-associated pneumonia due to resistant Gram-negative pathogens
por: Partridge, David, et al.
Publicado: (2008)

Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins
por: van der Heijden, Inneke M, et al.
Publicado: (2007)

65. Impact of a Multifaceted Stewardship Intervention on Oral Fosfomycin Prescribing for Treatment of Resistant Organisms in Cystitis
por: Pry, Marie, et al.
Publicado: (2020)

1417. Fosfomycin Use in the Treatment of Complicated Urinary Tract Infections at a Veterans Affairs Medical Center
por: Lee, Ryan, et al.
Publicado: (2021)

13. Evaluation of Etest for Antibiotic Susceptibility and Minimum Inhibitory Concentration (MIC) Agreement Against pseudomonas Aeruginosa (psa) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

2412. Our Experience With IV Fosfomycin
por: Savaj, Pratik, et al.
Publicado: (2018)

Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test
por: Croughs, Peter D., et al.
Publicado: (2022)

2164. Activity of Fosfomycin (FOF) and Frequency of Nonsusceptible Inner Colonies During Susceptibility Testing of an International Collection of Clinical Pseudomonas aeruginosa (PA) Isolates
por: Smith, Elizabeth C, et al.
Publicado: (2019)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017
por: Snayd, Mary, et al.
Publicado: (2018)

Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli: comparison between Etest and a broth dilution method
por: Azrad, Maya, et al.
Publicado: (2018)

2415. Comparison of Minocycline MIC’s Obtained by Etest to Those Obtained by Broth Microdilution in a Bank of Isolates of Acinetobacter baumannii Collected in Southeastern Michigan
por: Parsons, Leo, et al.
Publicado: (2018)

In vitro antimicrobial susceptibility of fosfomycin against organisms isolated from various clinical specimens: a multicentre trial from Kolkata
por: Chakraborty, A, et al.
Publicado: (2015)

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
por: Martín-Gutiérrez, Guillermo, et al.
Publicado: (2020)

XSL-FO
por: Pawson, Dave
Publicado: (2002)

Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study
por: Singh, Vikram, et al.
Publicado: (2012)

Comparison of M.I.C.E. and Etest with CLSI Agar Dilution for Antimicrobial Susceptibility Testing against Oxacillin-Resistant Staphylococcus spp
por: Campana, Eloiza H., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_peb1m3d5hjpprimgg3qk47h676